Related Experiment Videos
Serologic characteristics of different subpopulations of human non-T lymphocytes
Transplantation Proceedings
|June 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A new allele, HLA-DRB4*010304.
Tissue antigens·2003
Genotyping for cytokine polymorphisms: allele frequencies in the Italian population.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics·2003
New HLA-A*11 allele, A*1112, identified by sequence-based typing.
Tissue antigens·2002
Proficiency testing for HLA-DRB high-resolution typing: a 4-year experience in Italy.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics·2002
Comparison of different techniques for detection of anti-HLA antibodies in sera from patients awaiting kidney transplantation.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics·2002
Nephrectomy in Kidney Transplant Candidates With Autosomal Dominant Polycystic Kidney Disease.
Transplantation proceedings·2026
Comparison of Outcomes Between Obese and Non-Obese Pancreas Transplant Recipients Following Belatacept Conversion.
Transplantation proceedings·2026
The Role of Baseline Systemic Inflammatory Indices Predicting Long-Term Mortality in Kidney Transplant Recipients.
Transplantation proceedings·2026
High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.
Journal of human immunity·2026
Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.
International reviews of immunology·2026
Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Somatic Hypermutations Enhance Neutralization Breadth of IGHV3-53/3-66 Public Antibodies Against SARS-CoV-2 Variants.
Immunity, inflammation and disease·2026